All lobbying filings

TIBER CREEK GROUP

TIBER CREEK GROUP filed a Q3 report for CIGNA CORPORATION AND SUBSIDIARIES on October 19, 2025, reporting $90,000 in lobbying income.

Lobbying for CIGNA CORPORATION AND SUBSIDIARIES · Employee benefits company.

All filings by TIBER CREEK GROUP · Everything CIGNA CORPORATION AND SUBSIDIARIES has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 19, 2025

Income

$90,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy.

Health Issues

Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability; Issues related to tax and health coverage changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to competition in the health care marketplace.

Defense

Pharmacy issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Pharmacy issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026.

Bills named in this filing 2

H.R. 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
S. 2296
National Defense Authorization Act for Fiscal Year 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.